Altre lingue BioRegenx, Inc.

Azioni

BRGX

US31772N1000

Tempo differito OTC Markets Altri mercati azionari 17:28:31 25/06/2024			Variaz. 5gg	Var. 1 gen.
0,018 ^USD	-41,94%		-55,22%	-23,40%

08/03	BioRegenx, Inc. ha completato l'acquisizione di Findit, Inc. (OTCPK:FDIT) da WooEB, Inc., Hva Family Trust e altri in una transazione di fusione inversa.	CI
2023	Findit, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

BioRegenx : Non Reliance on Previously Issued Financial Report Form 8 K	11/06
FINDIT : Management Change/Compensation - Form 8-K	01/04
BioRegenx, Inc. completed the acquisition of Findit, Inc. from WooEB, Inc., Hva Family Trust and others in a reverse merger transaction.	08/03
Findit, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11
Findit, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/08/23
Findit, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	22/05/23
Findit, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	04/04/23
FINDIT, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	04/04/23
Findit, Inc. Auditor Raises 'Going Concern' Doubt	04/04/23
FINDIT, INC. : Entry into a Material Definitive Agreement (form 8-K)	06/01/23
BioRegenx, Inc. entered into a Definitive Agreement to acquire Findit, Inc. in a reverse merger transaction.	29/12/22
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21/11/22
Findit, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	21/11/22
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	12/08/22
Findit, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22
Findit : Announces Investor Update	29/07/22
Findit : Featured Member BioRegenx Announces Investor Update	19/07/22
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23/05/22
Findit, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	23/05/22
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	13/04/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BioRegenx, Inc.

Azioni

BRGX

US31772N1000

Altre lingue

Filtri